The regulation of cell adhesion and motility in human prostate is not well understood. We have previously shown that the endoglin gene is differently expressed during changes in prostate cell adhesion. Endoglin is a transmembrane transforming growth factor b binding protein typically expressed by endothelial cells. In this report we demonstrate that endoglin over expression increases prostate cell attachment, while decreasing migration and invasion. Engineered decreases in endoglin expression have opposite effects. While endoglin exerted only relatively small effects upon cell adhesion, large effects upon cell migration and invasion were observed. Endoglin was shown to localize to focal adhesion plaques, consistent with its role in regulating cell adhesion and motility. Loss of endoglin expression in cancer, as compared to normal prostate, was seen in human prostate cell lines. Suppression of endoglin expression in a panel of normal human prostate cell lines led to cell detachment. Endoglin is identified as a regulator of cell adhesion, motility and invasion in human prostate. Loss of endoglin expression appears to be associated with prostate cancer progression, at least in vitro.
Introduction
Changes in adhesion and motility in human prostate cancer accompany the development of metastasis. Changes in several adhesion and motility associated proteins have been identified. Differential expression of transmembrane integrin receptor subtypes, in prostate cancer as compared to normal prostate, has been reported by a number of investigators (Cress et al., 1995; Fornaro et al., 1996 Fornaro et al., , 1999 Meredith et al., 1995; Nagle et al., 1994) . Integrins are transmembrane proteins, which form heterodimers of a and b subunits, thus forming unique receptors which bind specific extracellular matrix proteins (Giancotti and Ruoslahti, 1999; Yamada, 1997) . Integrins cluster on the plasma membrane to form focal adhesion plaques, wherein their cytoplasmic tails bind to the actin cytoskeleton, via talin, a-actinin, and vinculin adapter proteins, thus anchoring cells through macromolecular structures known as focal adhesions (Sastry and Burridge, 2000) .
Focal adhesion kinase (FAK), is a protein -tyrosine kinase which plays a central role in adhesion-associated signaling (Hanks and Polte, 1997) . We (Liu et al., 2000 and others (Tremblay et al., 1996) have shown that FAK is up-regulated in prostate cancer. Inhibition of FAK kinase activity leads to apoptosis in human prostate (Kyle et al., 1997) . We have also shown that during cell adhesion, FAK translocates to focal plaques, and forms a complex with b1-integrin (Bergan et al., 1996b) . b1-integrin is a prevalent integrin subtype in human prostate (Bergan et al., 1996b; Cress et al., 1995; Kyle et al., 1997; Nagle et al., 1994; Witkowski et al., 1993) , and was recently shown by us to regulate FAK activity in human prostate (Liu et al., 2000) .
In order to better understand how prostate cells regulate adhesion and motility, we first characterized a panel human prostate cell lines, and measured their ability to attach to a solid matrix . We found that metastatic variant PC3-M cells exhibited a unique pattern of cell adhesion, characterized by rapid attachment, followed by detachment. Focusing upon genes important in regulating cell detachment, we developed a novel statistical approach wherein multiple replicates of gene array experiments were used to calculate mean and variance of gene expression, for all genes (Jovanovic et al., 2001; . In this manner, genes whose expression was significantly up-or downregulated, as compared to that associated with normal gene variance, could be identified, and investigated further. Unique amongst *4000 genes evaluated, endoglin exhibited a significant change in gene expression during prostate cell detachment.
Endoglin is typically expressed by endothelial, hematopoietic, and kidney mesangial cells (Gougos and Letarte, 1990) . It is a 180 kDa homodimeric type I transmembrane protein, which, when over expressed in mouse fibroblasts, leads to decreased cell migration (Guerrero-Esteo et al., 1999) . Endoglin is the gene mutated in Hereditary Hemorrhagic Telangiectasia type 1 (HHT1); a disorder characterized by aberrant arteriole -venous (A -V) malformations, presumably due to aberrant endothelial cell motility (McAllister et al., 1995) . Endoglin is expressed at high levels by human vascular endothelial cells (Gougos and Letarte, 1990) . Because new blood vessel formation is necessary to sustain metastatic deposits, it is not surprising that endoglin levels have recently been shown to be elevated in the serum of individuals with metastatic cancer (Takahashi et al., 2001) .
Endoglin has homology to transforming growth factor b (TGFb) receptor type III, will bind TGFb (Cheifetz et al., 1992) , and modulates TGFb signaling in several systems, inhibiting TGFb action in some (Lastres et al., 1996; Letamendia et al., 1998) , augmenting it in others (Altomonte et al., 1996) . TGFb is known to modulate cell adhesion and motility in a variety of cell types (Albo et al., 1997; Cai et al., 2000; Loganadane et al., 1999; Merzak et al., 1994; Teti et al., 1997) , including prostate (Festuccia et al., 1999) . Finally, endoglin contains the tripeptide motif, arg-glyasp (RGD) in its extracellular domain (Altomonte et al., 1996; Gougos and Letarte, 1990) . The RGD motif is associated with the extracellular matrix protein, fibronectin, and is the ligand by which fibronectin binds integrins (including b1-integrin) (Witkowski et al., 1993) .
Endoglin is known to bind TGFb, and by virtue of the fact that it also has an integrin binding motif, endoglin has the potential to interact with integrin proteins. TGFb, integrins, and the integrin-associated protein, FAK, all contribute to modulation of adhesion and motility. In addition, all have been associated with prostate cancer progression. As we have recently shown that changes in prostate adhesion are associated with changes in endoglin expression, we hypothesized that endoglin plays a role in regulating adhesion and motility in human prostate. In the current study, we demonstrate that endoglin does play a role in regulating prostate cell adhesion and motility.
Results

Endoglin is down-regulated during prostate cell detachment
After plating PC3-M cells onto a solid surface, cells attach for the first 2 h, peak, and then enter a detachment phase from 2 -4 h (Figure 1a) . Evaluation for longer periods of time show a reentry into cell attachment, but of lower magnitude than observed with the first cycle (unpublished observations). Prior gene array-based studies indicated that endoglin expression increased during cell detachment (Jovanovic et al., 2001) . However, array findings were never confirmed by Northern blot. As can be seen during cell detachment (3.5 h time point; Figure 1b) , the levels of the 17 kb immature endoglin transcript increased, thus accounting for the increase seen on gene array studies. Importantly, however, levels of the 3.4 kb mature endoglin transcript decreased during detachment. Probing for b-actin, and over exposing the blot demonstrated that the 17 kb band was not due to contaminating DNA. If endoglin were in fact responsible for regulating prostate cell adhesion, then expression of mature endoglin transcript should change in parallel with changes in cell adhesion. Assessment of In (b), change in endoglin expression with change in cell attachment was measured by Northern blot. Endoglin levels at time 0 (attached cells) and 3.5 h (detaching) were first compared. The blot was then reprobed with b-actin, and over exposed. Next, change in endoglin expression with different times after adhesion was evaluated. Included as controls are stably attached cells (SA; plated 24 h previously), as well as cells which were otherwise stably attached, but which had just been detached prior to RNA isolation (time 0 cells) Endoglin suppresses metastatic phenotype in prostate Y Liu et al this demonstrated that endoglin transcript levels did parallel changes in cell adhesion (Figure 1b) : increasing during the first 2 h, peaking, and decreasing thereafter. No change in endoglin expression was observed when transcript levels were compared between cells which had been adherent for 24 h (stably attached), and those which were immediately post detachment (time 0). Prior studies indicate significant changes in both structural proteins as well as cellular energy requirements during changes in cell adhesion (Bergan et al., 1996b; Liu et al., 2000 Liu et al., , 2001 . Thus, levels of gene expression were compared between equal numbers of cells, and equal gel loading confirmed by ethidium bromide staining of total RNA.
Endoglin regulates adhesion, motility, and invasion in human prostate
If endoglin were important in regulating cell adhesion, then changes in endoglin expression should affect cell adhesion. To investigate this, stably transfected endoglin over expressing and under expressing (i.e. antisense) single cell clones were selected under G418 growth conditions, and characterized. Endoglin has two isoforms, a long (L) and a short (S), which differ only by the number of amino acids in the cytoplasmic domain: 47 amino acids for L, and 14 for S (Bellon et al., 1993) . Both isoforms were evaluated. Four over expression clones (two L and two S), and four antisense clones, were evaluated for their ability to attach to a solid surface, 30 min after plating. Relative to wild type, vector control and sense control cells, endoglin over expressing cells exhibited a 31.7+4.5% (mean+s.e.m.; t-test P50.001) increase in cell adhesion, while antisense cells exhibited a 33.0+2.1% decrease (t-test P50.001); similar findings were observed at the 2 and 4 h post plating time points (data not shown). No differences in attachment were observed between L and S isoforms (P=0.39).
Two over expression cell lines (ENG-L and ENG-S; L and S isoforms, respectively) were selected for further evaluation, as were two antisense cell lines (AS1 and AS2). Endoglin transcript levels were 9.8 -15.3-fold higher in over expression clones, relative to wild type and vector control cells (P=0.03), and 3.8 -6.8-fold lower in antisense clones, relative to wild type, vector control and sense cells (P=0.01; Figure 2a ). Similar findings were seen when protein expression was evaluated ( Figure 2b ). In our experience, differences in endoglin protein expression, particularly at the relatively low levels seen antisense clones, are best measured by immunohistochemistry (unpublished observations). Endoglin protein levels were 3.4 -4.0-fold higher in over expression clones relative to wild a b c Figure 2c ). When endoglin was separated under non-reducing conditions, the native homodimeric 180 kDa protein was evident in cells transfected with endoglin-FLAG constructs, whereas under reducing conditions, the 90 kDa monomer was evident.
As endoglin is a transmembrane protein which affects cell adhesion, a logical expectation would be that it would localize to focal contacts within the plasma membrane. This was evaluated by examining d e In (b) endoglin protein expression was evaluated by immunohistochemical staining, and visualization with HRP-secondary antibody. Isotype (ISO) antibody controls were performed for all immunohistochemical studies. Surface expression of endoglin was evaluated in (c) by transfecting WT cells with endoglin-FLAG (F) or luciferase-FLAG control (C) constructs. Surface proteins were then biotinylated, and FLAG immunoprecipitated (FLAG-ip). Products of immunoprecipitation (from equal amounts of cell lysate protein), or pre-immunoprecipitation raw cell lysates (lysate), were separated by SDS -PAGE under either reducing or non-reducing conditions, and Western blots probed with HRP-strepavidin. Arrows indicate endoglin monomer or homodimer. In (d) the subcellular localization of endoglin was evaluated by immunofluorescent staining of cells plated 24 h previously, using FITC-conjugated secondary antibody to allow visualization. ENG-L cells were photographed first, and the images of all other cell types were recorded using the same exposure conditions as were used for ENG-L cells (i.e., equal exposure time), magnification 6006. In addition, for isotype antibody stained ENG-L cells, and for endoglin antibody stained wild type cells, exposure times were increased until cell images became apparent (extended exposure). In (e) co-localization of actin and endoglin was evaluated by staining ENG-L cells for actin and endoglin, 2 h after plating, and visualizing by confocal microscopy; panels are: (A) endoglin, (B) actin, (C) phase contrast, (D) composite endoglin expression in stably adherent cells by immunofluorescence. As can been seen in Figure 2d , endoglin did in fact exhibit focal localization to points of cell contact. This was investigated further by examining actin and endoglin co-localization within the cell by confocal microscopy. Prior investigations have shown that the actin network of PC3-M cells is disorganized relative to other prostate cell lines , consistent with its metastatic phenotype, and that organized actin networks are best visualized during changes (i.e., increases) in cell attachment (Bergan et al., 1996b) . Thus, co-localization of actin and endoglin was examined in ENG-L cells 2 h after plating ( Figure 2e ). As can been seen, endoglin colocalizes to areas of focal contact, particularly along the leading edge of the cell. Similar results were seen with ENG-S cells (data not shown). Endoglin's effects upon cell migration and invasion were examined next. In cell migration wound healing assays, endoglin over expressing cells migrated more slowly than controls, while antisense cells migrated more rapidly (Figure 3a) . Specifically, pair-wise comparison of data, performed as previously described (Games and Howell, 1976) , demonstrates a significant difference (at a=5% level) between endoglin over expressing cells and wild type or vector control cells, as well as between antisense and wild type, vector control or sense cells, at all time points evaluated. As wound healing assays span multiple days, it was important to make sure that increased wound gap closure was not due to a higher growth rate of antisense cells. To evaluate this possibility, the growth of endoglin clonal variant cell lines was measured. As can be seen (Figure  3b ), the growth rate of endoglin antisense cells was actually slightly lower than that of controls. Thus, differences in wound closure time were not due to differences in growth rate. When cell invasion was examined (Figure 3c ), endoglin over expressing cells exhibited a 2.0 -2.1-fold decrease in cell invasion, compared to wild type and vector control cells (P=0.002), whereas endoglin antisense cells exhibited a 2.1 -2.4-fold increase in invasion, compared to wild type, vector control and sense cells (P=0.03). In contrast to its relatively small effect upon cell adhesion, endoglin altered cell migration as well as cell invasion by at least twofold.
Evaluation of endoglin in other prostate cell lines
Above studies all dealt with the PC3-M cell line, and its derivative clones. Further investigations were therefore performed on additional human prostate cell lines. We recently completed a phenotypic characterization of a panel of human prostate cells lines . Within this panel, six cell lines were suitable for use in paired comparisons. HPV transformed normal prostate epithelium and prostate cancer cells, derived from the same prostate gland, were available from two separate prostate glands (i.e., four cell lines, constituting two pairs); normal/cancer cell line pairs were: 1532NPTX/1532CPTX, and 1542NPTX/1542CP3TX. Above findings suggest that loss of endoglin causes cell detachment, and may be associated with prostate cancer progression. If this were the case, then it would be expected that lowering of endoglin should lead to cell detachment in normal prostate cells. This was investigated by first characterizing the ability of endoglin antisense oligonucleotides to inhibit prostate cell adhesion in PC3-M cells. As recommended for oligonucleotide-based antisense experiments (Eckstein et al., 1996) , separate oligonucleotides, targeted to different non-overlapping DNA segments, were first tested, yielding two separate active antisense oligonua b c Figure 4 Significance of endoglin expression in human prostate. In (a) the expression of endoglin was evaluated in paired normal and cancer (nl-Ca), and parental and metastatic variant (parental-met) human prostate cell lines. Equal amounts of total RNA were loaded, and Northern blot for endoglin performed; lanes are: 1, 1532NPTX; 2, 1532CPTX; 3, 1542NPTX; 4, 1542CP3TX; 5, PC3; 6, PC3-M. The ability of endoglin antisense oligonucleotide to decrease prostate cell detachment was measured in (b) and (c). In (b), PC3-M cells were treated with 1, 5 or 10 mM antisense (AS 1, AS 5 or AS 10, respectively) for three days, or with the same concentration of sense (SE) oligonucleotide, as described in Materials and methods; control cells (CO) were not treated. Cells were then detached, and cell adhesion measured at 0.5, 2 and 3.5 h after replating, as described in Figure 1 . In (c) the effect of endoglin suppression was evaluated on the normal prostate cell lines: 1532NPTX, 1542NPTX, and NPEC. Cells were treated with 10 mM antisense for three days, and cell adhesion measured. For both (b) and (c), values are the mean+s.e.m. (n=4) of a single experiment, expressed as the per cent of adherent untreated control cells for a given time after plating (and in (c), for a given cell type). Similar results were seen in multiple replicate experiments (all n=4)
Endoglin suppresses metastatic phenotype in prostate Y Liu et al cleotides (antisense #1 and #2). The ability of antisense #1 to cause a dose-dependent decrease in cell attachment in PC3-M cells, relative to untreated and sense treated control cells, at all time points evaluated, is shown in Figure 4b . Next, the three normal prostate cell lines, 1532NPTX, 1542NPTX and NPEC, were treated with antisense #1, and effects upon cell adhesion measured (Figure 4c ). In three of three cell lines examined, endoglin antisense treatment led to cell detachment, at all time points examined, relative to sense and no treatment control cells. Similar effects were also seen with antisense #2 (data not shown).
Discussion
The ability of PC3-M cells to rapidly cycle between cell attachment and cell detachment is consistent with their metastatic phenotype, which we and others have previously characterized (Bergan et al., 1996b; Kozlowski et al., 1984; Kyle et al., 1997; Liu et al., 2001) . Importantly, PC3-M cells underwent spontaneous cell detachment in vitro, thereby providing a unique model with which to identify responsible regulatory factors. We had previously shown that endoglin was upregulated during cell detachment, as measured by gene arrays (Jovanovic et al., 2001) . It was therefore surprising to find that upon further analysis by Northern blot, that this was due to a marked increase in immature endoglin transcript, and mature transcript actually decreased during cell detachment. This finding lends credence to the notion that gene array data must be confirmed. Taken together, findings suggest that significant changes in transcriptional processing may be taking place, and warrant further investigation in future studies. Prior studies have implicated endoglin in the regulation of attachment and motility in fibroblast and endothelial cells (Gougos and Letarte, 1990; Guerrero-Esteo et al., 1999; Mcallister et al., 1995) . We had recently shown that endoglin was uniquely differentially expressed during prostate cell detachment, amongst 4000 other genes examined (Jovanovic et al., 2001 ). Thus, current investigations focused upon characterizing endoglin's functional role in human prostate. Increased endoglin expression was shown to increase prostate cell adhesion, while decreased expression had opposite effects. Changes in endoglin expression did not alter the cyclic attachmentdetachment behavior of cells (data not shown), consistent with the notion that endoglin is not the only molecule responsible for modulating this complex process. Overall, endoglin protein levels were low in wild type PC3-M cells. Immunohistochemical methods provided the most sensitive measure of further decreases in protein expression in antisense cells. This is likely due to the fact that this methodology coupled signal amplification with detection of native protein.
Further evidence supporting endoglin's role in regulating cell adhesion was provided by showing that endoglin localizes to focal adhesion complexes.
Surface biotinylation of endoglin-FLAG fusion protein constructs, provided definitive evidence of transmembrane expression. Since loss of membrane expression has been seen with mutant forms of endoglin, we felt it important to document transmembrane expression in artificial constructs (Pece- Barbara et al., 1999) . Furthermore, we felt it important to evaluate the function of both long (L) and short (S) endoglin isoforms. L and S isoforms differ only by the number of amino acids in the cytoplasmic tail: 47 for L and 14 for S (Bellon et al., 1993) . While the L isform is phosphorylated on three additional serine and threonine residues, no fuctional differences between the isoforms has been reported (Lastres et al., 1994) . In fact, Letamendia et al. (1998) show that endoglin-mediated regulation of TGFb signaling is a function which resides on endoglin's extracellular domain, which is identical between the two isoforms. No differences in function were identified in the current study, consistent with the findings of other investigators.
As changes in endoglin expression only led to relatively minor effects upon cell adhesion (i.e., as low as 25% relative to control), its biological significance could readily be questioned. However, it was hypothesized that small changes in cell adhesion would exert large effects upon the dependent processes of cell migration and invasion. Furthermore, it was hypothesized that decreased cell adhesion, due to lower endoglin expression, would facilitate cell migration and invasion. Data from the current study directly support these notions: altered endoglin expression affected both migration and invasion by twofold. Furthermore, decreased endoglin expression enhanced cell migration and invasion; while increased expression had opposite effects.
In vitro decreases in endoglin expression identified in the current study in human cancer and metastatic variant cell lines, compared to normal and parental counterparts, respectively, are consistent with the notion that loss of endoglin expression in vivo, by prostate epithelial cells, may accompany prostate cancer progression. In contrast to epithelial cells, endoglin is expressed at high levels on endothelial cells (Gougos and Letarte, 1990) . It is thus not surprising that increased endoglin expression has been seen in situations where there is an increase in microvessel density. For example, microvessel formation is required for the establishment of cancer metastasis, and high levels of circulating endoglin has been seen in people who have metastatic cancer (Takahashi et al., 2001 ).
In the current study, it was important to expand studies beyond a single cell line in order to determine the broader functional significance of endoglin in human prostate. These expanded studies directly support the notion that endoglin is an important regulator of cell adhesion and motility in human prostate epithelial cells. Seemingly in contrast to our findings, Sharma et al. (2002) report lower levels of endoglin transcript in a less metastatic variant Dunning rat prostate cell line clone, as compared to a more metastatic clone. However, it is unclear if there are real differences between the two studies. The more metastatic Dunning clone was actually a variant previously characterized as fibroblast-like, and fibroblasts are known to express high levels of endoglin (Luo et al., 1997) . Also, protein expression was not examined in Dunning cells, and prior studies have shown the importance of evaluating endoglin protein expression (Pece- Barbara et al., 1999) . Consistent with our findings, other investigators show that loss of endoglin protein expression is associated with increased cell migration (Guerrero-Esteo et al., 1999; McAllister et al., 1995) . As changes in adhesion and motility are prerequisites for development of prostate cancer metastasis, it will be important to evaluate endoglin's role in vivo in this regard. Further investigations will be required in order to determine the mechanism by which endoglin modulates cell adhesion, motility and invasion in human prostate.
Materials and methods
Cell culture
The origins and culture conditions for PC3, metastatic variant PC3-M, human papillomavirus (HPV) transformed paired (i.e., from the same patient) normal epithelial and primary cancer 1532NPTX (normal) and 1532CPTX (cancer), and 1542NPTX (normal) and 1542CP3TX (cancer) cells (a generous gift from S Topolian, National Cancer Institute, Bethesda, MD, USA), and normal prostate epithelial cells (NPECs), have been previously described (Bright et al., 1997; Kozlowski et al., 1984; Liu et al., 2001) .
Cell adhesion assay
Cell adhesion assays were performed as previously described (Bergan et al., 1996b; Liu et al., 2001) . Briefly, exponentially growing non-confluent cells were detached by trypsin/EDTA (Biofluids), and 10 4 cells added to each well of a 96-well culture plate (Corning Costar, Cambridge, MA, USA), in replicates of 4 -8. After incubation at 378C for the indicated time, non-adherent cells were removed by washing with phosphate buffered saline (PBS), and the number of remaining cells counted by light microscopy.
RNA isolation and Northern analysis
Total RNA was isolated with Trizol TM reagent (Life Technologies, Inc.), as previously described (Schwartz et al., 1998) . Total RNA, from an equal number of cells (*20 mg), was separated on a 1% agarose formaldehyde gel, transferred onto nylon membrane (Micron Seperations, Inc, Westborough, MA, USA), pre-hybridized in ExpressHyb TM . Hybridization solution (Clontech, Palo Alto, CA, USA), hybridized with random primed labeled probe (made using 32 P-dCTP (Amersham, Arlington Heights, IL, USA) and a Prime-It RmT random priming labeling kit (Stratagene, La Jolla, CA, USA), according to manufacturers instructions), and visualized by autoradiography, using Kodak X-O-MAT AR film at 7708C. Resultant autoradiographs were scanned into an electronic file on a Molecular Dynamics Personal Densitometer SI, coupled to a Dell high speed workstation. Individual bands were quantified with ImageQuant 5.0 software (Molecular Dynamics). Probes for Northerns were synthesized by PCR amplification of endoglin expression vector, or of PC3-M derived RNA (for b-actin), using the following exon spanning primers: endoglin probe (415 bp): 5'-CCAAGACCGGGTCTCAAGAC-3' (bases 1945 -1964) and 5'-CTGGGTCGAGTGGAGGACTG-3' (bases 2475 -2494); b-actin (154 bp), as reported (Dakhama et al., 1996) . Note that base pair numbering is based upon the longer endoglin-S isoform transcript, which contains an extra 135 bp insert, compared to the L isoform. However, this 135 bp insert contains an early stop codon, resulting in a shorter protein in the S isoform, compared to the L.
Antisense experiments
Oligonucleotides contained two phosphorothioate inter-base linkages at either end, and phosphodiester linkages in the center (i.e., hybrid oligonucleotides), whose properties (i.e., lower non-specific protein binding, and increased nuclease resistance) and synthesis were previously described (Bergan et al., 1993 (Bergan et al., , 1994 . Antisense oligonucleotides were targeted to two separate locations within the 3' untranslated region of the endoglin gene: site #1 (bases 2377 to 2394; AS1): 5'-GCTATGCCATGCTGCTGG-3'; site #2 (bases 2552 to 2571; AS2): 5'-TCCAAGCCAGTGGCTGCA CT-3' Twenty-four hours after plating, cells were treated with 1, 5 or 10 mM antisense, or sense control oligonucleotide, or not treated (control), for 3 days, after which cell adhesion to a solid matrix was measured (after removal of excess oligonucleotide from suspended cells by extensive washing).
Plasmid construction and cell transfection
Full-length endoglin-long (L) and -short (S) isoform complete open reading frame sequences were removed by EcoRI digest of previously described pcEXV-EndoL and pcEXV-EndoS expression vectors, respectively (generous gifts from Carmelo Bernabeu, Centro de Investigaciones Biologicas, CSIC, Madrid, Spain), and inserted into a pcDNA3 expression vector (Invitrogen) (Guerrero-Esteo et al., 1999) . Antisense constructs were obtained by PCR amplification (AmpliTaq DNA polymerase, Applied Biosystems) of a 497 bp fragment (bases 355 to 852 in the 5' untranslated region), using primers: 5'-CCATGTCCTGGCTGGCTT-3' and 5'-CAGAA-ACAGTCCATGTGACC-3'. Gel purified fragments were then added to EcoRI digested pcDNA3 vector, blunt ended by treatment with Klenov fragment (Promega), and ligated with T4 DNA ligase (Invitrogen).
Endoglin-FLAG fusion constructs were made by using full-length endoglin-L vector as a template. Endoglin-L, minus the stop codon, was amplified using EcoR1-endoglin upstream, 5'-TTGAATTCCGTGGACAGCATGGACCG-3' and endoglin-HindIII downstream, 5'-TTAAGCTTTGC-CATGCTGCTGGTGGAG-3' chimeric primers, and inserted into a pCMV-Tag FLAG vector (Stratagene). Final vector is endoglin-L without stop codon, followed by a three amino acid linker region (NLQ), ending with the eight amino acid FLAG peptide sequence (DYKDDDDK) on the C-terminus. All resultant vectors were confirmed by sequencing, yielding: antisense, sense, full-length native endoglin-L and endoglin-S open reading frame, as well as full-length endoglin-L-FLAG fusion constructs. In addition, Stratagene provides a luciferase-FLAG control vector. PC3-M cells were transfected with Lipofectamine Reagent (GIBCO, Gaithersburg, MD, USA), per manufacturers' instructions, and single cell clones selected in the presence of G418. For endoglin-FLAG experiments, cells were used 48 h after transfection.
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Biotinylation and immunoprecipitation of endoglin-FLAG
Exponentially growing subconfluent cells, in a 10 cm tissue culture dish, were washed 62 with PBS, and biotinylated as described, with modifications (Schoenenberger et al., 1994) . Briefly, cells were labeled with EZ-link sulfo-NHS-Biotin (Pierce Chemical Co) at 500 mg/ml in PBS for 1 h at 48C, washed with PBS, incubated with 100 mM Glycine/PBS for 20 min at 48C, and washed with PBS. Cells were then lysed as described , with modifications, in phosphate buffered saline (PBS), pH 7.4, containing 1% Triton X-100 and 1 mM sodium orthovanadate, in the presence of the following protease inhibitors: 10 mg/ml aprotinin, 20 mg/ml leupeptin, and 1 mM PMSF (all from Sigma). After incubating for 15 minutes at 48C, lysates were clarified by centrifugation at 12 0006g for 20 min. Equal amounts of protein from endoglin-FLAG, or luciferase-FLAG control cells, were then subjected to immunoprecipitation with 40 ml anti-FLAG M2 antibody, pre-conjugated to agarose (Sigma), for 1 h at 48C with rotation, and then washed 63 in lysis buffer. Resultant immunoprecipitates were separated on a 7% sodium dodecyl sulfate polyacrylamide gel. Proteins were then transferred onto 0.45 mm nitrocellulose (Schleicher and Schuell Inc., Keene, NH, USA) in a wet transfer cell (Bio-Rad), blots blocked with 5% nonfat dry milk, probed with strepavidin-horseradish peroxidase (HRP; Sigma), and visualized with the ECL detection system (Amersham), according to the manufacturer.
Wound healing cell migration assay
Wound healing assays were performed as previously described (Goldfinger et al., 1999) . Briefly, 2.5 -10610 4 cells were seeded into each well of a 6-well plate in RPMI 1640 medium supplemented with 10% FCS. After incubating 24 -48 hours, a 'wound' was created by scraping the confluent portion of cells with the tip of a sterile 1 ml plastic pipette tip, thereby removing a defined and reproducible area. The residual monolayers were washed twice, overlaid with fresh growth media, and the wound gap measured every 24 h. Wound gaps were measured by prospectively identifying four areas within each wound, measuring the width of the wound at those areas, and calculating the mean+s.e.m. of the wound gap. Evaluation of the growth rates of stably transfected endoglin clones, based upon colorimetric detection of reduced dimethylthiazoldiphenytetrazolium bromide (MTT), was performed as previously described (Kyle et al., 1997) .
Trans-well invasion assay
The trans-well invasion assay was performed as described, with modifications (Jimenez et al., 2000) . Briefly, cells in serum-free RPMI culture medium, containing 0.1% BSA (Sigma, St. Louis, MO, USA), were placed into the upper chamber of a Boyden chamber apparatus (Neuroprobe Inc., Gathersberg, MD, USA), and allowed to invade through a polycarbonate membrane with 8 mm pores (Nucleopore), coated with gelatin (Difco), toward 3T3 conditioned medium in the lower chamber, for 9 h at 378C. After staining membranes with Diff Quick TM (Baxter), the number of migrating cells was counted by examination under a light microscope.
Immuno-staining for endoglin
Twenty-four hours after plating, cells were fixed in 3.7% formaldehyde at room temperature, permeabilized with 0.5% Triton X-100 in PBS at 48C for 5 min, stained for endoglin with a DAKO Catalyzed Signal Amplification kit (DAKO, Carpinteria, CA, USA), per manufacturer's instructions, using mouse anti-human monoclonal endoglin antibody clone SN6h (DAKO) diluted 1:2000. For immunoflorescent studies, a FITC-conjugated goat anti-mouse secondary antibody (Roach Molecular Biochemicals) was used, and slides were mounted with Slow Fade TM (Molecular Probes Inc., Eugene, OR, USA). Cells were visualized on a Nikon Labophot epifluorescence microscope (Tokyo, Japan), and images captured with an Optronics DEI-750 digital camera (Optronics Engineering, Goleta, CA, USA) linked to a workstation with Adobe Photoshop TM software (Adobe Systems Incorporated, San Jose, CA, USA). The intensity of stained cells was quantitated using ImageJ version 1.27 software (NIH, Bethesda, MD, USA). In some experiments, cells were costained for F-actin by adding rhodamine-phalloidin (Molecular Probes) during the second antibody step, according to manufacturers' instructions. Confocal images were obtained on a Zeiss LSM 510 Laser Scanning/Confocal Microscope, coupled to a 486/50 MS-DOS/Windows based microprocessor system, which includes a magneto-optical drive for storage of digital images. In some experiments, cell surface expression of endoglin was quantitated by FACS analysis, as previously described (Bergan et al., 1996a) , using endoglin antibody clone SN6h, as described by the manufacturer.
Abbreviations FAK, focal adhesion kinase; HPV, human papillomavirus; PBS, phosphate buffered saline; SDS, sodium dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain reaction; PMSF, phenylmethylsulfonylfluoride; HRP, horse radish peroxidase; FCS, fetal calf serum; MTT, dimethylthiazoldiphenytetrazolium bromide; FACS, flow activated cell sorting.
